Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character).

Simen Svendsen VatnA CarstensA B KristoffersenD BergemalmC CasénA E F MoenT M TannaesJ LindstrømTrond Espen DetlieC OlbjørnC M LindquistJ D SöderholmF GomollónR KallaJ SatsangiM H VatnProf Jørgen JahnsenJ HalfvarsonP Ricaneknull null

Published in: Scandinavian journal of gastroenterology (2020)

Our data reveal that the GA-map™ Dysbiosis Test holds the potential to characterize the faecal microbiota composition and to assess the degree of dysbiosis in new-onset IBD. On the other hand, our results cannot demonstrate any proven diagnostic or predictive value of this method to support clinical decision making.

Keyphrases

decision making
ulcerative colitis
genome wide
pet ct
oxidative stress
rheumatoid arthritis
electronic health record
single cell
big data
clinical trial
dna methylation
risk assessment
human health
data analysis
replacement therapy
artificial intelligence
deep learning
smoking cessation